Nine Masts Capital LTD Abbott Laboratories Transaction History

Nine Masts Capital LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$81.84 - $88.74 $982,080 - $1.06 Million	-12,000 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$72.88 - $85.0 $313,384 - $365,500	4,300 Added 55.84%	12,000 $1.01 Million
Q1 2019 May 06, 2019	BUY	$66.22 - $80.06 $509,894 - $616,462	7,700 New	7,700 $616,000
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $787,780 - $890,680	-14,000 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$53.68 - $57.47 $751,520 - $804,580	14,000	14,000 $799,000

3,208

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $224B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Nine Masts Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Nine Masts Capital LTD with notifications on news.